Literature DB >> 3918526

Detection and prevalence of serotypes of feline syncytial spumaviruses.

R L Flower, G E Wilcox, R D Cook, T M Ellis.   

Abstract

Three serotypes of feline syncytial virus (FSV) were detected by neutralisation tests: 906, a serotype of low prevalence and 702 and 951 which were serotypes of higher prevalence, between which a minor one-way antigenic difference was detected. Serum antibody in naturally-infected cats in some cases neutralised 951 but not 702 or 906 which suggested that 951 could be considered as a major distinct serotype. An increase in prevalence of antibody to FSV in cats over a 5 year period from 1977-1981 was detected by neutralisation, agar gel immunodiffusion, and fluorescent antibody techniques. Over the 5 year period the prevalence of antibody to the 951 serotype increased and the overall increase in prevalence of antibody to FSV during this period appeared to relate to dissemination of the 951 serotype.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918526     DOI: 10.1007/bf01310964

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  An unusual case of feline leukemia and an associated syncytium-forming virus.

Authors:  J E Whitman; K O Cockrell; W T Hall; C E Gilmore
Journal:  Am J Vet Res       Date:  1975-07       Impact factor: 1.156

2.  Feline viruses. XI. Isolation of a virus similar to a myxovirus from cats in which urolithiasis was experimentally induced.

Authors:  C G Fabricant; L J Rich; J H Gillespie
Journal:  Cornell Vet       Date:  1969-10

3.  Characteristics of a virus isolated from a feline fibrosarcoma.

Authors:  G E McKissick; P H Lamont
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

4.  Infection by feline syncytium-forming virus in Britain.

Authors:  O Jarrett; D Hay; H M Laird
Journal:  Vet Rec       Date:  1974-03-09       Impact factor: 2.695

5.  Microbial studies of feline urolithiasis.

Authors:  C G Fabricant; L J Rich
Journal:  J Am Vet Med Assoc       Date:  1971-03-15       Impact factor: 1.936

6.  Syncytium-forming agent isolated from domestic cats.

Authors:  J L Riggs; D O Taylor; E H Lennette
Journal:  Nature       Date:  1969-06-21       Impact factor: 49.962

7.  Isolation of a virus from a cat sarcoma in an established canine melanoma cell line.

Authors:  L Kasza; A H Hayward; A O Betts
Journal:  Res Vet Sci       Date:  1969-03       Impact factor: 2.534

8.  Recovery of viral agents from the central nervous system of cats.

Authors:  G E Wilcox; R L Flower; R D Cook
Journal:  Vet Microbiol       Date:  1984-08       Impact factor: 3.293

9.  Feline chronic progressive polyarthritis.

Authors:  N C Pedersen; R R Pool; T O'Brien
Journal:  Am J Vet Res       Date:  1980-04       Impact factor: 1.156

10.  Isolation of feline syncytia-forming virus from oropharyngeal swab samples and buffy coat cells.

Authors:  E L Shroyer; M R Shalaby
Journal:  Am J Vet Res       Date:  1978-04       Impact factor: 1.156

View more
  15 in total

1.  Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses.

Authors:  J Bodem; M Löchelt; I Winkler; R P Flower; H Delius; R M Flügel
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

2.  Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses.

Authors:  I Winkler; J Bodem; L Haas; M Zemba; H Delius; R Flower; R M Flügel; M Löchelt
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.

Authors:  Astrid Schwantes; Uwe Truyen; Joachim Weikel; Christian Weiss; Martin Löchelt
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

4.  Feline Foamy Virus Infection: Characterization of Experimental Infection and Prevalence of Natural Infection in Domestic Cats with and without Chronic Kidney Disease.

Authors:  Carmen Ledesma-Feliciano; Ryan M Troyer; Xin Zheng; Craig Miller; Rachel Cianciolo; Matteo Bordicchia; Nicholas Dannemiller; Roderick Gagne; Julia Beatty; Jessica Quimby; Martin Löchelt; Sue VandeWoude
Journal:  Viruses       Date:  2019-07-19       Impact factor: 5.048

Review 5.  Feline leukemia/sarcoma viruses and immunodeficiency.

Authors:  J Rojko; M Essex; Z Trainin
Journal:  Adv Vet Sci Comp Med       Date:  1988

6.  Isolation of bovine foamy virus in Japan.

Authors:  Yuma Hachiya; Kumiko Kimura; Keisuke Oguma; Mamiko Ono; Tetsuya Horikita; Hiroshi Sentsui
Journal:  J Vet Med Sci       Date:  2018-09-03       Impact factor: 1.267

Review 7.  Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission.

Authors:  Timo Kehl; Juan Tan; Magdalena Materniak
Journal:  Viruses       Date:  2013-09-13       Impact factor: 5.048

8.  Important role of N108 residue in binding of bovine foamy virus transactivator Tas to viral promoters.

Authors:  Tiejun Bing; Suzhen Zhang; Xiaojuan Liu; Zhibin Liang; Peng Shao; Song Zhang; Wentao Qiao; Juan Tan
Journal:  Virol J       Date:  2016-06-30       Impact factor: 4.099

9.  Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.

Authors:  Carmen Ledesma-Feliciano; Sarah Hagen; Ryan Troyer; Xin Zheng; Esther Musselman; Dragana Slavkovic Lukic; Ann-Mareen Franke; Daniel Maeda; Jörg Zielonka; Carsten Münk; Guochao Wei; Sue VandeWoude; Martin Löchelt
Journal:  Retrovirology       Date:  2018-05-16       Impact factor: 4.602

10.  Potent neutralizing antibodies in humans infected with zoonotic simian foamy viruses target conserved epitopes located in the dimorphic domain of the surface envelope protein.

Authors:  Caroline Lambert; Mathilde Couteaudier; Julie Gouzil; Léa Richard; Thomas Montange; Edouard Betsem; Réjane Rua; Joelle Tobaly-Tapiero; Dirk Lindemann; Richard Njouom; Augustin Mouinga-Ondémé; Antoine Gessain; Florence Buseyne
Journal:  PLoS Pathog       Date:  2018-10-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.